ImmunoGen Alternatives & Competitors
12 companies similar to ImmunoGen — Focusing on core therapeutic areas such as immunology, oncology, neuroscience, e...
Companies similar to ImmunoGen
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
ProfoundBio
An oncology biotherapeutics company
Woodinville, United State...
Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
London, United Kingdom
Rival Readout
Competing with ImmunoGen? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
GammaDelta Therapeutics
GammaDelta Therapeutics focuses on using γδ T cells to improve survival rates of patients...
London, United Kingdom
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
Peptomyc
Developing Peptides to treat Cancer
Barcelona, Spain
TC BioPharm
Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP
United Kingdom
Antikor Biopharma Ltd
Innovating in and developing the next generation of smaller-format ADCs for cancer therapy...
Stevenage, United Kingdom
About ImmunoGen
ImmunoGen, Inc. is a biotechnology innovator, harnessing the potential of antibody-drug conjugates (ADCs) to revolutionize cancer treatment. With a focus on oncology, the company combines the precision of antibodies with the effectiveness of cytotoxic drugs, aiming to target cancer cells while sparing healthy tissues.
Drug Development, Clinical Trials Management, Cancer Research and Treatment Solutions, Healthcare Professional Support
Cancer Patients, Oncologists, Healthcare Providers, Research Institutions
Antibody-drug Conjugates, Cancer Treatment, Oncology, Immunology, Neuroscience, Therapeutics Development, Targeted Antibody Payload (TAP) Technology, Metastatic Breast Cancer, Hematological Malignancies, Solid Tumors, Collaboration Agreements, Licensing Partnerships
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ImmunoGen: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ImmunoGen on 10 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
